Warden Charles M 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Warden Charles M
Director
Transactions
- Other
Common Stock
2021-02-15−1,456,780→ 0 total(indirect: See footnote) - Other
Common Stock
2021-02-15−375,121→ 0 total(indirect: See footnote) - Other
Common Stock
2021-02-15−8,604→ 0 total(indirect: See footnote) - Other
Common Stock
2021-02-15+375,121→ 375,121 total(indirect: See footnote) - Other
Common Stock
2021-02-15+35,912→ 39,531 total
Footnotes (8)
- [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital III, L.P. ("Versant III"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F2]Shares held by Versant III. Versant Ventures III, LLC ("Versant Ventures III GP") is the general partner of Versant III. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant III; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
- [F3]Represents a change in the form of ownership of Versant Ventures III GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant III.
- [F4]Shares held by Versant Ventures III GP. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures III GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
- [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures III GP to its members.
- [F6]Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Venture III GP.
- [F7]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund III, L.P. ("Versant Side Fund"), to its partners, pursuant to a Rule 10b5-1 trading plan.
- [F8]Shares held by Versant Side Fund. Versant Ventures III GP is the general partner of Versant Side Fund. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.